Microcarriers Industry Research Report: by Product Type (Equipment, Consumables, Reagents and Microcarrier Beads), by Application (Vaccine Manufacturing, Biologics Manufacturing and others), by End User (Research Institutes, and others) - Global Forecast Till 2023
The Global Microcarriers Industry Growing with positive signs of surpassing a valuation of USD 1.18 Billion with a moderately strong CAGR of 5.9% that can be taken into consideration for a forecast period defining the market from 2018 to 2023. The report published by Market Research Future (MRFR) claims better market potential as several factors are in sync to provide the needed tailwind to the market.
A microcarrier can be defined as a support matrix that would allow the growth of adherent cells. It can benefit from a number of factors like large culture surface area, better cell yields, and reduced risk of contamination can provide advantage to the global market for microcarriers. Various companies and research institutes can also make sure that the growth goes beyond the expected market rate.
But the market for microcarriers can find some distraction in the production of high-density cell culture as there are certain restrictions and also high cost that have to be considered to make an assessment of the market. Other factors like the manufacturing of biologics and cell therapies, can make adverse impact on the market growth due to its high cost.
Companies that have been included in the global market for microcarriers are GENERAL ELECTRIC COMPANY, Thermo Fisher Scientific Inc., Sartorius AG, Corning Incorporated, Becton, Dickinson and Company, Danaher, Merck KGaA, HiMedia Laboratories, Eppendorf AG, Lonza, and others. MRFR enlisted these companies in their latest report and profiled them for a better analytical approach to the market.
Microcarriers Market Segmentation:
The global microcarriers market can be assessed on the findings of segments like product type, application, and end-user. MRFR’s report provides a detailed glimpse into the market that can be shared to make a better assessment of the market.
By type, the market for microcarriers can be segmented into equipment, and consumables. The market, considering equipment, includes filtration systems, cell counters, bioreactors, culture vessels, and other equipment. The market, considering consumables, includes reagents, media, and microcarrier beads. The market, regarding media, includes serum-free media, serum-based media, and other media. The market, upon considering microcarrier beads reveals protein-coated microcarriers, collagen-coated microcarriers, cationic microcarriers, and other microcarrier beads.
By application, the market for microcarriers includes biologics manufacturing, cell therapy, vaccine manufacturing, and other applications.
By end-user, the market for microcarriers can be segmented into research institutes, pharmaceutical & biotechnology companies, and contract research organizations. The pharmaceutical & biotechnology companies segment has the potential to beat its peers and top the market in terms of revenue generation. The research institutes segment can be the fastest growing one due to increasing influx of various investment fund.
Microcarriers Market Regional Analysis:
The Americas is topping the chart as the research scope is better than other regions due to its superior infrastructure and favorable reimbursement scenarios. The regional market can be segmented into North America and South America of which the North is expected to fetch in considerable revenue due to better performance from countries like the US and Canada.
Europe’s market is expecting similar growth curve as several of these countries are showing immense possibilities in taking the regional market ahead. The regional market is banking on France, the UK, Spain, Germany, and others. This growth finds better traction from hike in research funds where a lot of funds are coming from various biopharmaceutical companies.
The Asia-Pacific region is all set to chart the course with the fastest CAGR during the forecast period. The regional market is relying on high number of patient population and growing demand for cell-based vaccines.
The Middle East and Africa (MEA) can make significant progress due to growing investment in the Middle Eastern countries like Dubai, Israel, and others.